جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.
YA

Yara Aboushark

بانتظار توثيق الانتساب2022–2026
2وثائق Scopus
0استشهاداً
0مؤشر h
0منها بانتماء الجامعة
إجمالي Scopus (كل الجهات)
مراجعةوصول مفتوح2026

A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy

Cureus · مجلد 18 (1) · e101744-e101744

Oncolytic virotherapy employs genetically modified viruses to selectively lyse tumor cells while activating antitumor immune responses. In pediatric oncology, where outcomes for high-grade gliomas and refractory solid tumors remain poor, oncolytic viruses represent a promising therapeutic strategy. A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, including searches of PubMed, Embase, Scopus, Web of Science, and ClinicalTrials.gov for studies published between 2015 and 2025 that evaluated oncolytic virotherapy in patients aged 18 years or younger. Data on safety, efficacy, and immune-related outcomes were extracted, study quality was assessed using the Risk Of Bias In Non-randomized Studies - of Interventions (ROBINS-I) tool, and the certainty of evidence was evaluated using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework. Ten early-phase clinical trials involving 115 pediatric patients met the inclusion criteria. Investigated viral platforms included herpes simplex virus type 1 (G207, HSV1716), adenovirus (DNX-2401, ICOVIR-5, Ad-TD-nsIL12), T-VEC (HSV-1), poliovirus (PVSRIPO), Seneca Valley virus, and reovirus. Across studies, no treatment-related deaths or persistent grade 3 or higher toxicities were reported, and adverse events were generally mild and transient. Radiologic or clinical disease control rates ranged from 20% to 90%, with median overall survival between 11 and 18 months in selected central nervous system tumor cohorts. Translational analyses demonstrated increased CD8⁺ T-cell infiltration, upregulation of interferon-γ and interleukin-6 signaling pathways, and evidence of transient viral replication, supporting immune-mediated antitumor mechanisms. Overall risk of bias was moderate, while the certainty of evidence was rated as low for safety outcomes and very low for efficacy. These findings indicate that oncolytic virotherapy is safe, feasible, and biologically active in children with malignant brain and solid tumors, and that preliminary survival signals and consistent immune activation support further investigation through larger, multicenter randomized trials and combination strategies with radiotherapy or immune checkpoint inhibitors.

oncolytic virotherapychildhood cancerhigh-grade gliomarefractory solid tumors
مقالمفتوح (مستودع)2022

Effect of exercise on adult asthmatic patients in Riyadh 2022

Medical Science · مجلد 26 (128) · 1-7

Background: Asthma is a chronic inflammatory disease of the airways characterized by wheezing; shortness of breath, chest tightness, and coughing that varies in severity and duration over time.The aim is to assess the effects of physical activity in adult asthma patients in Riyadh in 2022.Methods: A cross-sectional study contains an online questionnaire which composed of a message addressing the respondent and the purpose of the survey; the respondent's health status and the outcomes before and after exercising.Data collected in January-February 2022.Statistical Package for the Social Sciences (SPSS) helped analyze data and present the results.Suitable statistical tests of significance were used, considering a significant p-value of < 0.05.Results: A total of 143 participants, 81% were female, the mean age was 23.8, 92% were non-smokers, and 68% used inhalers for relief.Before exercising: 60% were asymptomatic, affected sleep in 79%, 50% took medications and 53% had daily activity limitations.After exercising: 66% were asymptomatic, 73% had sleep problems and 45% took medications with no daily limitations in 51%.13% of participants had pre-exercise asthma control, and 11% remained controlled post-exercise.45% suffered from partially controlled asthma, and 30% became partially controlled.43% had uncontrolled asthma and 42% were still uncontrolled.There is a statistically significant link between inactivity and asthma control p = 0.001.Conclusion: This data proves that exercise is a positive factor for asthmatic patients to decrease the frequency of medication usage and the incidence of sleep disturbances.

asthmaphysical activityasthma controlsleep disorders